Literature DB >> 31511258

A Role for the Orphan Human Cytochrome P450 2S1 in Polyunsaturated Fatty Acid ω-1 Hydroxylation Using an Untargeted Metabolomic Approach.

Mostafa I Fekry1, Yi Xiao1, Jeannette Zinggeler Berg1, F Peter Guengerich2.   

Abstract

Cytochrome P450 (P450) 2S1 is one of the orphan P450s, known to be expressed but not having a defined function with an endogenous substrate or in drug oxidations. Although it has been clearly demonstrated to catalyze reductive reactions, its role in NADPH-dependent oxidations has been ambiguous. In our efforts to characterize orphan human P450 enzymes, we used an untargeted liquid chromatography-mass spectromterymetabolomic approach with recombinant human P450 2S1 and extracts of rat stomach and intestine, sites of P450 2S1 localization in humans and animals. The search yielded several candidates, including the product 19-hydroxyarachidonic acid. Subsequent 18O analysis and in vitro studies with commercial arachidonic acid and 19-hydroxyarachidonic acid were used to validate ω-1 hydroxylation of the former molecule as a NADPH- and O2-dependent reaction. Steady-state kinetic assays were done for ω-1 hydroxylation reactions of P450 2S1 with several other long-chain fatty acids, including arachidonic, linoleic, α-linolenic, eicosapentaenoic, and docosapentaenoic acids. Rates of hydroxylation were slow, but no detectable activity was seen with either medium-chain length or saturated fatty acids. P450 2S1 is known to be expressed, at least at the mRNA level, to the extent of some other non-3A subfamily P450s in the human gastrointestinal tract, and the activity may be relevant. We conclude that P450 2S1 is a fatty acid ω-1 hydroxylase, although the physiologic relevance of these oxidations remains to be established. The metabolomic approaches we employed in this study are feasible for orphan P450s and other enzymes, in regard to annotation of function, in mammals and other organisms. SIGNIFICANCE STATEMENT: An untargeted mass spectrometry approach was utilized to identify ω-1 hydroxylation of arachidonic acid as an oxidative reaction catalyzed by human cytochrome P450 2S1. The enzyme also catalyzes the relatively slow ω-1 hydroxylation of several other unsaturated long-chain fatty acids.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31511258      PMCID: PMC6800448          DOI: 10.1124/dmd.119.089086

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  51 in total

1.  Identification of a novel dioxin-inducible cytochrome P450.

Authors:  Steven P Rivera; Sirkku T Saarikoski; Oliver Hankinson
Journal:  Mol Pharmacol       Date:  2002-02       Impact factor: 4.436

2.  Proteomics. Tissue-based map of the human proteome.

Authors:  Mathias Uhlén; Linn Fagerberg; Björn M Hallström; Cecilia Lindskog; Per Oksvold; Adil Mardinoglu; Åsa Sivertsson; Caroline Kampf; Evelina Sjöstedt; Anna Asplund; IngMarie Olsson; Karolina Edlund; Emma Lundberg; Sanjay Navani; Cristina Al-Khalili Szigyarto; Jacob Odeberg; Dijana Djureinovic; Jenny Ottosson Takanen; Sophia Hober; Tove Alm; Per-Henrik Edqvist; Holger Berling; Hanna Tegel; Jan Mulder; Johan Rockberg; Peter Nilsson; Jochen M Schwenk; Marica Hamsten; Kalle von Feilitzen; Mattias Forsberg; Lukas Persson; Fredric Johansson; Martin Zwahlen; Gunnar von Heijne; Jens Nielsen; Fredrik Pontén
Journal:  Science       Date:  2015-01-23       Impact factor: 47.728

3.  Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.

Authors:  Diane Downie; Morag C E McFadyen; Patrick H Rooney; Margaret E Cruickshank; David E Parkin; Iain D Miller; Colin Telfer; William T Melvin; Graeme I Murray
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

4.  Efficient hypoxic activation of the anticancer agent AQ4N by CYP2S1 and CYP2W1.

Authors:  Clinton R Nishida; Melody Lee; Paul R Ortiz de Montellano
Journal:  Mol Pharmacol       Date:  2010-06-21       Impact factor: 4.436

5.  Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.

Authors:  Meera Kumarakulasingham; Patrick H Rooney; Sinclair R Dundas; Colin Telfer; William T Melvin; Stephanie Curran; Graeme I Murray
Journal:  Clin Cancer Res       Date:  2005-05-15       Impact factor: 12.531

6.  Localization of cytochrome P450 CYP2S1 expression in human tissues by in situ hybridization and immunohistochemistry.

Authors:  Sirkku T Saarikoski; Harriet A-L Wikman; Gillian Smith; C Henrik J Wolff; Kirsti Husgafvel-Pursiainen
Journal:  J Histochem Cytochem       Date:  2005-05       Impact factor: 2.479

7.  Profiling the expression of cytochrome P450 in breast cancer.

Authors:  Graeme I Murray; Siva Patimalla; Keith N Stewart; Iain D Miller; Steven D Heys
Journal:  Histopathology       Date:  2010-08       Impact factor: 5.087

8.  Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques.

Authors:  Timo Frömel; Karin Kohlstedt; Rüdiger Popp; Xiaoke Yin; Khader Awwad; Eduardo Barbosa-Sicard; Anita C Thomas; Ralf Lieberz; Manuel Mayr; Ingrid Fleming
Journal:  Basic Res Cardiol       Date:  2012-12-07       Impact factor: 17.165

Review 9.  Lipid peroxidation: physiological levels and dual biological effects.

Authors:  Etsuo Niki
Journal:  Free Radic Biol Med       Date:  2009-06-24       Impact factor: 7.376

10.  Elucidation of functions of human cytochrome P450 enzymes: identification of endogenous substrates in tissue extracts using metabolomic and isotopic labeling approaches.

Authors:  Zhongmei Tang; Martha V Martin; F Peter Guengerich
Journal:  Anal Chem       Date:  2009-04-15       Impact factor: 6.986

View more
  4 in total

1.  Methylene Oxidation of Alkyl Sulfates by Cytochrome P450BM-3 and a Role for Conformational Selection in Substrate Recognition.

Authors:  F Peter Guengerich; Mostafa I Fekry
Journal:  ACS Catal       Date:  2020-04-02       Impact factor: 13.084

Review 2.  Lipid Dyshomeostasis and Inherited Cerebellar Ataxia.

Authors:  Jin Zhao; Huan Zhang; Xueyu Fan; Xue Yu; Jisen Huai
Journal:  Mol Neurobiol       Date:  2022-04-14       Impact factor: 5.682

3.  Cytochrome b 5 Binds Tightly to Several Human Cytochrome P450 Enzymes.

Authors:  Donghak Kim; Vitchan Kim; Yasuhiro Tateishi; F Peter Guengerich
Journal:  Drug Metab Dispos       Date:  2021-07-30       Impact factor: 3.579

Review 4.  Inhibition of Cytochrome P450 Enzymes by Drugs-Molecular Basis and Practical Applications.

Authors:  F Peter Guengerich
Journal:  Biomol Ther (Seoul)       Date:  2022-01-01       Impact factor: 4.634

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.